Allergy Treatment Market Report 2024 (Global Edition)

Global Allergy Treatment Market Report 2024 Market Size Split by Type (Eye Allergy, Food Allergy, Skin Allergy, Asthma, Rhinitis, Others), by Treatment (Anti-Allergy Drugs, Immunotherapy), by Route of...

Allergy Treatment Market Report Description

We have various report editions of Allergy Treatment Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Competitive Landscape of the Allergy Treatment market

The competitive landscape of the allergy treatment market is characterized by a dynamic interplay of pharmaceutical innovators, research institutions, and healthcare providers. Major players strive for market dominance through strategic partnerships, product expansions, and advancements in treatment modalities. Continuous research and development initiatives, coupled with a focus on personalized solutions, define the competitive edge.

Allergy Treatment Industry News

In March 2021, Glenmark collaborates with Bausch to market a nasal spray in Canada. As per the agreement, Glenmark will handle regulatory approvals and supply Ryaltris for the Canadian market, while Bausch Health, Canada, will oversee the product's commercialization post-regulatory approval.

Source-www.prnewswire.com/in/news-releases/glenmark-and-bausch-health-join-together-to-commercialize-ryaltris-tm-nasal-spray-in-canada-827572047.html

Top Companies Market Share in Allergy Treatment Industry: (In no particular order of Rank)

• Akorn Incorporated
• Pfizer Inc.
• GlaxoSmithKline plc
• Novartis AG
• Mylan N.V.
• Teva Pharmaceutical Industries Ltd.
• Sanofi
• Boehringer Ingelheim International GmbH.
• Glenmark
• Johnson & Johnson Private Limited 
• Bayer AG
• Merck & Co. Inc.
• Prestige Consumer Healthcare Inc.
• F. Hoffmann-La Roche Ltd.
• Bristol-Myers Squibb Company
• Almirall S.A
• Zenomed Healthcare Private Limited
• Cadila Pharmaceuticals
• Astellas Pharma Inc.
• Eli Lilly and Company
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

In terms of revenue, the North America Allergy treatment Market share was 40% of the total marke

According to Cognitive Market Research, North America dominated the market in 2023 and accounted for around 40% of the global revenue. The region's robust healthcare infrastructure, coupled with high awareness levels and extensive research and development initiatives, positions it as a primary hub for allergy treatment innovation. Moreover, a well-established insurance framework and elevated healthcare spending contribute to the region's market supremacy. The concentration of pharmaceutical giants and strategic alliances further fortify North America's leadership, ensuring a resilient and flourishing market presence. In this dynamic landscape, the region continues to shape and steer the trajectory of the allergy treatment market through its multifaceted strengths.

Asia-Pacific is the fastest-growing region. The rapid growth of cities a growing class and increased awareness, about allergies are all contributing to the expansion of the market. Additionally there is an increase in healthcare investments and initiatives to address disorders, which further enhance the potential for growth. The Asia Pacific regions openness to technologies, combined with the increasing prevalence of allergies is driving demand for innovative treatment options. With Asia Pacific leading the way in healthcare trends there is a shift happening in the allergy treatment market that presents exciting opportunities, for those involved in this dynamic and evolving field.

The current report Scope analyzes Allergy Treatment Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Allergy Treatment

According to Cognitive Market Research, the global Allergy treatment market size was estimated at USD 20,584.20 Million out of which North America held the major market of around 40% of the global revenue with a market size of USD 8233.68 million in 2023 and will grow at a compound annual growth rate (CAGR) of 6.7% from 2023 to 2030. The region's well-established insurance frameworks contribute to increased patient accessibility to innovative treatments. As healthcare spending continues to rise, North America remains at the forefront of allergy treatment advancements, with personalized solutions and advanced therapies driving sustained market expansion. Asthma, anticipates a sales surge propelled by heightened awareness, advanced healthcare infrastructure, and a proactive shift toward precision medicine. The region's commitment to respiratory well-being and a nuanced approach to asthma management ensures a robust market trajectory, fostering innovation and accessibility.

• According to Cognitive Market Research, the US had a major share in the allergy treatments market with a market size of USD 6496.37 million in 2023 and is projected to grow at a CAGR of 6.5% during the forecast period. The sales of allergy treatment in the U.S. are set to surge due to a robust healthcare infrastructure, heightened awareness, and a burgeoning aging population susceptible to allergic conditions.
• The Canada allergy treatments market had a market share of USD 988.04 million in 2023 and is projected to grow at a CAGR of 7.5% during the forecast period. In Canada, increasing healthcare investments, supportive government policies, and a growing emphasis on personalized medicine propel the sales of allergy treatments. The country's diverse allergen profiles contribute to demand.
• The Mexico allergy treatments market is projected to witness growth at a CAGR of 7.2% during the forecast period with a market size of USD 749.26 million in 2023.

Europe Allergy Treatment

According to Cognitive Market Research, with a market value of USD 20,584.20 million in 2023 and projected to expand at a compound annual growth rate (CAGR) of 8.50% from 2023 to 2030, Europe accounted for a share of around 30% of the global market size of USD 6,175.26 million. The region's commitment to addressing allergic disorders is underscored by supportive government policies that prioritize research and development. Europe's evolving healthcare dynamics position it as a pivotal player in the global allergy treatment market, with a trajectory defined by progressive research and tailored interventions. Anti-allergy drugs in Europe foresee an upswing in sales, driven by a confluence of factors. Europe's eco-conscious healthcare landscape, coupled with government-backed research initiatives, positions these drugs as integral to allergy treatment. The region's multicultural dynamics further spur demand for diverse anti-allergy medications, fostering a flourishing market.

• According to Cognitive Market Research, the Germany allergy treatments market size was valued at USD 1222.70 million in 2023 and is projected to grow at a CAGR of 7.2% during the forecast period. Sales of allergy treatment in Germany will rise with the nation's commitment to eco-friendly healthcare practices, advanced medical technologies, and a multicultural demographic demanding tailored allergy solutions. 
• The United Kingdom allergy treatments market had a market share of USD 1037.44 million in 2023 and is projected to grow at a CAGR of 7.8% during the forecast period. In the UK, the increasing prevalence of allergies, coupled with a robust healthcare system, drives demand for innovative treatments. Government support and a proactive approach to allergy management further boost sales.
• The France allergy treatments market is projected to witness growth at a CAGR of 6.2% during the forecast period with a market size of USD 568.12 million in 2023.
• The Italy allergy treatments market is projected to witness growth at a CAGR of 6.4% during the forecast period with a market size of USD 531.07 million in 2023.
• The Russia allergy treatments market is projected to witness growth at a CAGR of 6.0% during the forecast period with a market size of USD 957.17 million in 2023.
• The Spain allergy treatments market is projected to witness growth at a CAGR of 6.1% during the forecast period with a market size of USD 506.37 million in 2023.
• The Portugal allergy treatments market is projected to witness growth at a CAGR of 6.8% during the forecast period with a market size of USD 129.68 million in 2023.
• The Luxembourg allergy treatments market is projected to witness growth at a CAGR of 7.1% during the forecast period with a market size of USD 191.43 million in 2023.
• The Greece allergy treatments market is projected to witness growth at a CAGR of 7.3% during the forecast period with a market size of USD 74.10 million in 2023.
• The Rest of Europe allergy treatments market is projected to witness growth at a CAGR of 5.7% during the forecast period with a market size of USD 957.17 million in 2023.

Asia Pacific Allergy Treatment

According to Cognitive Market Research, the global Allergy treatment market size was estimated at USD 20,584.20 Million out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 4,734.37 million in 2023 and will grow at a compound annual growth rate (CAGR) of 10.5% from 2023 to 2030. The region's receptiveness to advanced medical technologies, combined with rising healthcare investments, stimulates demand for innovative allergy treatments. A surge in allergic disorders, linked to lifestyle changes and environmental factors, underscores the need for accessible and effective solutions. Inhalation, as a preferred route of administration in the Asia-Pacific, propels sales growth. The region's rapid urbanization, coupled with a surge in respiratory conditions, fuels demand for efficient inhalation therapies. Asia-Pacific's embrace of advanced medical technologies ensures a flourishing market for inhalation-based allergy treatments, marking a transformative healthcare landscape.

• According to Cognitive Market Research, the China allergy treatments market size was valued at USD 2130.46 million in 2023 and is projected to grow at a CAGR of 10.0% during the forecast period. The sales of allergy treatment in China are poised for growth due to rapid urbanization, rising healthcare investments, and a shift towards online healthcare platforms, ensuring widespread accessibility.
• The India allergy treatments market had a market share of USD 568.12 million in 2023 and is projected to grow at a CAGR of 12.3% during the forecast period. India's sales of allergy treatment will surge with a growing middle class, increasing awareness, and a diverse environmental landscape contributing to a rise in allergic conditions, fostering demand for effective solutions.
• The Japan allergy treatments market is projected to witness growth at a CAGR of 9.0% during the forecast period with a market size of USD 653.34 million in 2023.
• The South Korea allergy treatments market is projected to witness growth at a CAGR of 9.6% during the forecast period with a market size of USD 473.44 million in 2023.
• The Australia allergy treatments market is projected to witness growth at a CAGR of 10.2% during the forecast period with a market size of USD 246.19 million in 2023.
• The South East Asia allergy treatments market is projected to witness growth at a CAGR of 11.5% during the forecast period with a market size of USD 326.67 million in 2023.
• The Rest of Asia Pacific allergy treatments market is projected to witness growth at a CAGR of 10.3% during the forecast period with a market size of USD 336.14 million in 2023.

South America Allergy Treatment

According to Cognitive Market Research, the global Allergy treatments market size was estimated at USD 20,584.20 Million out of which Latin America market holds around 5% of the global revenue with a market size of USD 1,029.21 million in 2023 and will grow at a compound annual growth rate (CAGR) of 7.9% from 2023 to 2030. The region's diverse climate and ecosystems contribute to a range of allergic conditions, necessitating a rise in demand for effective treatment options. Government initiatives to improve healthcare infrastructure and accessibility further enhance the market landscape. Retail pharmacy, spearheading distribution in Latin America, is set for increased sales. The region's diverse climate and ecosystems contribute to varying allergic conditions, making retail pharmacies vital hubs for accessible and diverse allergy treatments. Proactive government initiatives further solidify the role of retail pharmacies in fostering healthcare accessibility.

• According to Cognitive Market Research, the Brazil allergy treatments market size was valued at USD 440.50 million in 2023 and is projected to grow at a CAGR of 8.5% during the forecast period. Sales of allergy treatment in Brazil are set to increase due to a proactive approach to environmental sustainability, a diverse climate fostering varied allergies, and government initiatives enhancing healthcare accessibility.
• The Argentina allergy treatments market had a market share of USD 172.91 million in 2023 and is projected to grow at a CAGR of 8.8% during the forecast period. Argentina's allergy treatment sales will rise with increasing healthcare investments, a burgeoning awareness of allergies, and unique environmental factors contributing to diverse allergic conditions, creating demand for effective treatments.
• The Colombia allergy treatments market is projected to witness growth at a CAGR of 7.7% during the forecast period with a market size of USD 91.60 million in 2023.
• The Peru allergy treatments market is projected to witness growth at a CAGR of 8.1% during the forecast period with a market size of USD 74.10 million in 2023.
• The Chile allergy treatments market is projected to witness growth at a CAGR of 8.2% during the forecast period with a market size of USD 74.10 million in 2023.
• The Rest of Latin America allergy treatments market is projected to witness growth at a CAGR of 7.0% during the forecast period with a market size of USD 165.70 million in 2023.

 

Middle East and Africa Allergy Treatment

According to Cognitive Market Research, the global Allergy treatment market size was estimated at USD 20,584.20 Million out of which Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 411.68 million in 2023 and will grow at a compound annual growth rate (CAGR) of 8.2% from 2023 to 2030. Governments in the region are actively promoting medical tourism, attracting patients seeking specialized allergy treatments. Additionally, a rising middle class and increasing disposable incomes contribute to the affordability and accessibility of advanced allergy therapies, positioning the MEA region as an emerging player in the global allergy treatment market. Hospitals, as primary end-users in the MEA region, anticipate a surge in sales due to a growing prevalence of allergies and enhanced healthcare investments. The region's commitment to advanced allergy treatments positions hospitals as integral hubs for comprehensive patient care, ensuring sustained market growth.

• According to Cognitive Market Research, the GCC Countries allergy treatments market size was valued at USD 176.20 million in 2023 and is projected to grow at a CAGR of 9.0% during the forecast period. Sales of allergy treatment in GCC countries will increase due to a rising prevalence of allergies, government support for healthcare infrastructure, and a focus on attracting medical tourism for specialized treatments.
• The South Africa allergy treatments market had a market share of USD 65.05 million in 2023 and is projected to grow at a CAGR of 9.2% during the forecast period. South Africa's allergy treatment sales will surge with growing healthcare investments, a rising middle class, and diverse environmental factors contributing to a spectrum of allergies, fostering demand for advanced treatments.
• The Egypt allergy treatments market is projected to witness growth at a CAGR of 8.5% during the forecast period with a market size of USD 43.23 million in 2023.
• The Turkey allergy treatments market is projected to witness growth at a CAGR of 7.7% during the forecast period with a market size of USD 35.40 million in 2023.
• The Nigeria allergy treatments market is projected to witness growth at a CAGR of 7.3% during the forecast period with a market size of USD 43.23 million in 2023.
• The Rest of MEA allergy treatments market is projected to witness growth at a CAGR of 7.2% during the forecast period with a market size of USD 48.58 million in 2023.

Allergy Treatment Market Analysis

Allergy treatment Market, By Type Segment Analysis

According to Cognitive Market Research, asthma held the major market share over the forecast period. Its prevalence and chronic nature contribute to sustained market leadership, with therapeutic advancements continuously addressing the evolving needs of patients. The demand for effective and accessible asthma management solutions propels innovation, fostering a competitive landscape that prioritizes respiratory well-being.

Skin allergy is the fastest-growing category over the forecast period. The dynamic surge in its prominence underscores a shifting landscape where skin-related allergic conditions demand heightened attention. This rapid growth signifies an evolving understanding of dermatological allergies, prompting the development of innovative treatments to meet the expanding needs of patients seeking comprehensive skin allergy management.

• Eye Allergy
• Food Allergy
• Skin Allergy
• Asthma
• Rhinitis
• Others

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Allergy Treatment Industry. Request a Free Sample PDF!

Allergy treatment Market, Treatment Segment Analysis

According to Cognitive Market Research, anti-allergy drugs hold a prominent market share. The therapeutic arsenal of anti-allergy drugs continues to evolve, offering patients varied options for symptom relief. Their prevalence underscores the reliance on pharmacological interventions, reflecting the enduring need for accessible and efficient allergy treatments tailored to individual needs.

Immunotherapy is the fastest-growing category over the forecast period. Its accelerated growth mirrors a broader trend in healthcare, as advancements in immunomodulatory approaches gain traction. The increasing recognition of immunotherapy's potential to modify allergic responses propels its ascent, marking a transformative era in allergy treatment dynamics. This category's rapid progression underscores a commitment to long-term solutions that address the root causes of allergic conditions.

• Anti-Allergy Drugs
• Immunotherapy

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Allergy Treatment Route of Administration Segment Analysis

According to Cognitive Market Research, inhalation hold a prominent market share. The preference for inhalation routes reflects a strategic approach to delivering swift relief, especially for respiratory conditions. The ease of administration and direct targeting of affected areas contribute to its enduring popularity, creating a seamless experience for patients seeking effective and rapid alleviation of allergy symptoms.

Intranasal is the fastest-growing category over the forecast period, showcasing an evolution in how allergy treatments are delivered. This nasal route offers a precise and patient-friendly approach, capturing attention for its efficacy in addressing a spectrum of allergic conditions. The surge in its prominence signifies a paradigm shift, aligning with a patient-centric approach that prioritizes comfort and convenience in allergy treatment, thereby reshaping the forecast period's treatment landscape. 

• Oral
• Inhalation
• Intranasal
• Others

Allergy Treatment Distribution Channel Segment Analysis

According to Cognitive Market Research, retail pharmacy hold a prominent market share. The accessibility and community-centric nature of retail outlets make them go-to destinations for allergy treatment solutions. This prominence underscores the pivotal role these pharmacies play in ensuring widespread availability of a diverse range of treatments, creating a seamless experience for consumers seeking over-the-counter remedies and prescription medications alike.

Online pharmacy is the fastest-growing category over the forecast period. The convenience of virtual access to allergy treatments positions online platforms at the forefront of market growth. This category's rapid ascent reflects a broader trend in healthcare digitization, presenting a dynamic landscape where patients increasingly turn to online avenues for personalized, hassle-free procurement of allergy management solutions over the forecast period.

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Allergy Treatment End-Users Segment Analysis

According to Cognitive Market Research, hospitals holds a prominent market share. The centralized and comprehensive nature of healthcare institutions positions them as primary hubs for diagnosing and managing various allergic conditions. The intricate interplay between specialized healthcare professionals and state-of-the-art facilities within hospitals underscores their significance, ensuring a robust market presence for the treatment and care of diverse allergic disorders.

Homecare is the fastest-growing category over the forecast period. The rise, in the provision of care at home represents a shift from healthcare models as more and more patients are looking for tailored solutions within the familiarity of their own homes. This changing trend is transforming how treatments are approached, placing an emphasis on putting the patient at the centre and aligning with the projected growth of home based care in the allergy treatment market, during the forecast period.

• Hospitals
• Specialty Clinics
• Homecare
• Others

Author's Detail

David Fuller

Senior Analyst at Cognitive Market Research

LinkedIn

Profile

I am working as a Senior Analyst with Cognitive Market Research in the areas of Industry Survey and Market Research/Analytics. I collaborate with CXOs, VPs, and other senior executives to understand their data needs and provide solutions and business strategy building.

Author's Conclusion